| Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance JJ Alumkal, D Sun, E Lu, TM Beer, GV Thomas, E Latour, R Aggarwal, ... Proceedings of the National Academy of Sciences 117 (22), 12315-12323, 2020 | 100 | 2020 |
| A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone JN Graff, TM Beer, JJ Alumkal, RE Slottke, WL Redmond, GV Thomas, ... Journal for immunotherapy of cancer 8 (2), 2020 | 92 | 2020 |
| Association between postpartum breast cancer diagnosis and metastasis and the clinical features underlying risk ET Goddard, S Bassale, T Schedin, S Jindal, J Johnston, E Cabral, ... JAMA network open 2 (1), e186997-e186997, 2019 | 89 | 2019 |
| Comparison of three diagnostic frameworks for pyoderma gangrenosum C Haag, T Hansen, T Hajar, E Latour, J Keller, K Shinkai, ... Journal of Investigative Dermatology 141 (1), 59-63, 2021 | 61 | 2021 |
| Inpatient teledermatology: diagnostic and therapeutic concordance among a hospitalist, dermatologist, and teledermatologist using store-and-forward teledermatology JJ Keller, JP Johnson, E Latour Journal of the American Academy of Dermatology 82 (5), 1262-1267, 2020 | 42 | 2020 |
| Ipilimumab-induced hypophysitis, a single academic center experience T Snyders, D Chakos, U Swami, E Latour, Y Chen, M Fleseriu, M Milhem, ... Pituitary 22, 488-496, 2019 | 37 | 2019 |
| Evaluation of the effectiveness and tolerability of mycophenolate mofetil and mycophenolic acid for the treatment of morphea M Arthur, NM Fett, E Latour, H Jacobe, E Kunzler, S Florez-Pollack, ... JAMA dermatology 156 (5), 521-528, 2020 | 26 | 2020 |
| Using a multimedia tool for informed consent in Mohs surgery: a randomized trial measuring effects on patient anxiety, knowledge, and satisfaction M Delcambre, D Haynes, T Hajar, S Golden, A Bar, E Latour, ... Dermatologic Surgery 46 (5), 591-598, 2020 | 26 | 2020 |
| Missing data in primary care research: importance, implications and approaches M Marino, J Lucas, E Latour, JD Heintzman Family Practice 38 (2), 199-202, 2021 | 22 | 2021 |
| Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma SE Spurgeon, K Sharma, DF Claxton, C Ehmann, J Pu, S Shimko, ... British Journal of Haematology 186 (6), 845-854, 2019 | 21 | 2019 |
| Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review E Sawka, A Zhou, E Latour, M Friedman, AG Ortega-Loayza Clinical Rheumatology 40 (10), 3963-3969, 2021 | 18 | 2021 |
| Pyoderma gangrenosum study pilot registry: the first step to a better understanding VE Orfaly, AM Reese, M Friedman, E Latour, AG Ortega‐Loayza Wound Repair and Regeneration 30 (3), 334-337, 2022 | 17 | 2022 |
| Phase II study of ipilimumab in men with metastatic prostate cancer with an incomplete response to androgen deprivation therapy JN Graff, MN Stein, R Surana, L Al Rabadi, E Liu, L Fong, S Bailey, ... Frontiers in Oncology 10, 1381, 2020 | 15 | 2020 |
| Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum CK Haag, AG Ortega-Loayza, E Latour, JJ Keller, NM Fett Journal of Dermatological Treatment, 2019 | 15 | 2019 |
| Invasive melanoma and melanoma in situ treated with modified Mohs micrographic surgery with en face permanent sectioning: a 10-year retrospective review M Heath, M Woody, J Leitenberger, E Latour, A Bar Dermatologic Surgery 46 (8), 1004-1013, 2020 | 14 | 2020 |
| Perioperative management of pyoderma gangrenosum CK Haag, L Bacik, E Latour, DC Morse, NM Fett, AG Ortega-Loayza Journal of the American Academy of Dermatology 83 (2), 369-374, 2020 | 14 | 2020 |
| Past, present, and future shared decision-making behavior among patients with eczema and caregivers IJ Thibau, AR Loiselle, E Latour, E Foster, WS Begolka JAMA dermatology 158 (8), 912-918, 2022 | 13 | 2022 |
| Wound care dressings for pyoderma gangrenosum JL Strunck, B Cutler, E Latour, L Seminario-Vidal, AG Ortega-Loayza Journal of the American Academy of Dermatology 86 (2), 458-460, 2022 | 9 | 2022 |
| Treatment of pyoderma gangrenosum: A multicenter survey‐based study assessing satisfaction and quality of life MM Hobbs, R Byler, E Latour, L Bonomo, K Hennessy, CN Cruz‐Diaz, ... Dermatologic Therapy 34 (2), e14736, 2021 | 9 | 2021 |
| Predictors of Virologic Failure Among a Cohort of HIV-infected Children in Southern Ethiopia BT Tadesse, BA Foster, E Latour, JY Lim, D Jerene, A Ruff, E Aklillu The Pediatric Infectious Disease Journal 40 (1), 60-65, 2021 | 8 | 2021 |
